3 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
Follow Hepatitis D: new trials by email Literature Review of Hepatitis D trials Research Report on Hepatitis D
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection Ursodeoxycholic acid, Ropeginterferon alfa-2b, Tenofovir Alafenamide - Hepatitis D | Phase 2 | Unknown | National Taiwan University Hospital | 30 | 2023-02-24 | 2022-12-29 |
| Ezetimibe for Patients With Chronic Hepatitis D Ezetimibe - Chronic Hepatitis D | Phase 2 | Unknown | Ziauddin Hospital | 20 | 2017-01-01 | 2017-04-04 |
| Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D Pegylated interferon alfa, Ezetimibe - Hepatitis D, Chronic | Phase 2 | Unknown | Aga Khan University | 20 | 2016-01-01 | 2017-04-07 |
Digestive System Diseases (3) · Hepatitis (3) · Hepatitis, Viral, Human (3) · Infections (3) · Liver Diseases (3) · RNA Virus Infections (3) · Virus Diseases (3) · Chronic Disease (2) · Disease Attributes (2) · Hepatitis, Chronic (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Ezetimibe (2) · Ursodeoxycholic Acid (1) · tenofovir alafenamide (1)
Aga Khan University (1) · National Taiwan University Hospital (1) · Ziauddin Hospital (1)
Pakistan (1) · Taiwan (1)
Pei-Jer Chen (1)